PeptideStack
5.2kquestions
20kanswers
220users

Does TSH tell me anything about hepatic fat on dulaglutide?

Asked 13 Jan 2025Modified 16 months agoViewed 26k times
40

What I have: TSH · dulaglutide.

I can predict the outcome but I cannot explain it, which means I will get the next case wrong.

I would like to know how confident the field actually is about this.

Can someone derive this rather than assert it?

liver-enzymes
liver-enzymes

ALT, AST, GGT and ALP: what they do and do not indicate about hepatic fat, why enzymes are a poor surrogate for histology, and where non-invasive…

91 questions
mash
mash

Metabolic dysfunction-associated steatohepatitis: histological endpoints, resolution without worsening fibrosis, fibrosis improvement by stage,…

56 questions
bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
thyroid
thyroid

Thyroid questions: the rodent C-cell findings behind the labelled warning, human calcitonin data, TSH drift during weight loss, and the…

23 questions
dulaglutide
dulaglutide

A once-weekly GLP-1 receptor agonist built on an Fc fusion rather than fatty-acid acylation. Use this tag for questions about the fusion-protein…

200 questions
shareeditfollowflag
SI
askedsample_id17k2713 Jan 2025

5 Answers

Accepted answer first, then by votes
24

Accepted answer

Before attributing anything to a compound, account for alcohol, muscle injury from new training, and any over-the-counter product being taken alongside.

Alanine aminotransferase is relatively liver-specific; aspartate aminotransferase is also present in muscle, heart and red cells. A raised AST with a normal ALT after heavy resistance training is usually muscle, and creatine kinase settles the question.

Very rapid weight loss can transiently worsen liver biochemistry, which is one of several arguments against pursuing the steepest possible trajectory.

Hy's law and its variants are the standard framework for identifying drug-induced liver injury in trials and are why bilirubin is measured alongside transaminases rather than instead.

The caveat is direct: rising liver enzymes with jaundice, dark urine or right-upper-quadrant pain is a same-day clinical problem, not a forum question.

Get a baseline before you start anything, because it converts an uninterpretable result into an interpretable one for the cost of one blood draw.

shareimprove this answerflag
DV
answered · acceptedDr_Bram_Verhoeven84k24821 Feb 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
18

The relevant caution is that a rapid rise, particularly with bilirubin, is a different event from a stable mild elevation and needs handling differently.

Weight loss of ten per cent or more typically reduces transaminases substantially in people whose elevation was driven by hepatic fat, which is the majority of mild elevations in this population.

Hy's law describes the combination that matters: transaminases above three times the upper limit together with bilirubin above twice the upper limit and no cholestatic explanation. That combination is a signal; isolated mild transaminase elevation is not.

Research-use material of unknown content is an unquantifiable variable in any such attribution.

Read the pattern before the magnitude, and the magnitude in multiples of the upper limit.

edited 14 Mar 2025 by fib4_reader — removed a claim I could not source

shareimprove this answerflag
FR
answeredfib4_reader24k274 Mar 2025
5Worth flagging that a mild enzyme elevation with a normal bilirubin is a different object from a rising one. – mg_per_ml 9 months ago
add a comment
11

This is one of the areas where the trend across several measurements is far more informative than any single result.

Gamma-glutamyl transferase is sensitive and unspecific: it rises with alcohol, with several medications and with fatty liver, and an isolated elevation rarely changes anything on its own.

The relevant detail is that an isolated result three weeks after starting anything is difficult to interpret. A baseline taken before starting makes the same result trivially interpretable, which is the argument for baselines.

Population data show a substantial fraction of adults with mild transaminase elevation attributable to hepatic steatosis, which sets the base rate against which any new finding should be read.

New training, alcohol and over-the-counter products first. Then the interesting hypotheses.

shareimprove this answerflag
ED
answerede_dziedzic51k14726 Mar 2025
8Worth adding that the collection tube and how long the tourniquet was on move several of these analytes. – s_kalniete 9 months ago
add a comment
9

The honest answer is that mild elevation is very common, that it usually improves with weight loss, and that the exceptions are the reason anyone checks.

Reference upper limits around forty units per litre for ALT are conventional rather than physiological; several groups have argued for limits closer to thirty for men and twenty-five for women.

Attributing an enzyme change to a compound requires a baseline, and most people asking have not got one.

Transaminases plus bilirubin plus alkaline phosphatase, or you have not measured enough to conclude anything.

shareimprove this answerflag
EB
answeredelke_brunner17k2815 Mar 2025
Delta checks against your own previous value are the part I had not thought about, and it reframes the whole panel. – nkem_obiora 4 months ago
8Adding a vote because this deserves more of them. – marta_okonkwo 3 months ago
add a comment
8

Answer first: mild transaminase elevation is common in this population before any drug is involved, and the usual cause is hepatic steatosis rather than anything acute.

Creatine kinase, alkaline phosphatase and bilirubin together tell you which compartment the abnormality is in, and ordering the transaminases alone throws that information away.

Nothing here is medical advice. An abnormal result needs somebody who can take a history and examine you.

Isolated mild elevation is common and usually improves with weight loss.

shareimprove this answerflag
ZM
answeredzainab_mustafa21k2718 Jan 2025
2Small correction: eGFR is an estimate derived from creatinine, not a measurement, and the equation used matters. – tenth_of_a_unit 1 days ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.